Clinical Study to Assess Efficacy and Safety of Amiodarone in Treating Patients With Ebola. Virus Disease (EVD) in Sierra Leone. EASE (EMERGENCY Amiodarone Study Against Ebola)

• Status: Withdrawn
• Trial end date: 2015-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the efficacy and safety of amiodarone in the treatment of patients afflicted with Ebola virus disease.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Emergency NGO Onlus
• Treatments: Amiodarone; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• patient admitted to the Emergency ETC at Goderich with a clinical diagnosis of Ebola virus disease;

• patient who consent to participate in the study.

Exclusion Criteria:

• negative RT-PCR tests for Ebola virus

• age <2 years

• state of shock upon admission

• onset of fever for more than 6 days

• Glasgow Coma Scale <12

• known contraindications to administration of amiodarone

• positive for HIV antibodies.